Zurich Cantonal Bank’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Zurich Cantonal Bank’s Portfolio MACK Stock Details MACK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-449	Closed	-$5K	–	2617
2017 Q3	$5K	Hold	449	–	–	﹤0.01%	2504
2017 Q2	$4K	Hold	449	–	–	﹤0.01%	2513
2017 Q1	$11K	Hold	449	–	–	﹤0.01%	2467
2016 Q4	$14K	Buy	449 +104	+30%	+$4.43K	﹤0.01%	2383
2016 Q3	$17K	Hold	345	–	–	﹤0.01%	2291
2016 Q2	$15K	Hold	345	–	–	﹤0.01%	2244
2016 Q1	$23K	Hold	345	–	–	﹤0.01%	1954
2015 Q4	$21K	Buy	345 +205	+146%	+$14.4K	﹤0.01%	2054
2015 Q3	$9K	Buy	140 +85	+155%	+$6.94K	﹤0.01%	2171
2015 Q2	$5K	Hold	55	–	–	﹤0.01%	2003
2015 Q1	$5K	Buy	+55	New	+$4.68K	﹤0.01%	1994

Other funds holding MACK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Zurich Cantonal Bank's MACK Position: Q4 2017 in Review

Zurich Cantonal Bank sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q4 2017, closing a stake of 449 shares — an estimated $5K sold.

Zurich Cantonal Bank first reported a position in MACK in Q1 2015 and held it in 11 quarters. The position peaked at $23K in Q1 2016. 78 funds tracked by Wall St. Rank hold MACK as of Q4 2017.

Zurich Cantonal Bank reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
Zurich Cantonal Bank sold 449 Merrimack Pharmaceuticals, Inc. shares in Q4 2017, an estimated $5K.
Zurich Cantonal Bank first reported a position in Merrimack Pharmaceuticals, Inc. in Q1 2015 and held it in 11 quarters.
Zurich Cantonal Bank's Merrimack Pharmaceuticals, Inc. position peaked at $23K in Q1 2016.
78 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q4 2017.

Based on Zurich Cantonal Bank's 13F filing for Q4 2017, filed 31 Jan 2018.